Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Journal
Document Type
Year range
1.
Heart ; 107(SUPPL 1):A57-A58, 2021.
Article in English | EMBASE | ID: covidwho-1325132

ABSTRACT

Background The covid-19 pandemic has had a profound impact on healthcare service delivery. Acute cardiovascular care however remains a priority despite the pandemic. Patients presenting with non-ST elevation MI (NSTEMI) have been poorly characterized during the pandemic. Methods We conducted a retrospective study of patients diagnosed with NSTEMI during the peak of the pandemic between April-May 2020 at our tertiary centre in the UK. Data were collected from electronic patient clinical records including time from admission to angiography, length of stay, mortality, prescription of secondary prevention pharmacotherapy, and referral to cardiac rehabilitation. We compared this data to the same time period in 2019. Results As can be seen from table 1, in 2020, the mean age, median time to angiography, and length of stay were all significantly lower than the control period of 2019. Prescription of secondary prevention medication (Aspirin, P2Y12 inhibitor, Beta-blocker, Statin, and ACEi/ARB) and referral to cardiac rehabilitation also improved in 2020, however, neither was statistically significant. During the 2020 period, 1 patient died due to late presentation NSTEMI and multi-organ failure. There were 3 deaths in 2019: complications following coronary bypass surgery, upper GI bleed and a subarachnoid haemorrhage. Table 1 Comparison of NSTEMI patients in 2019 and 202020192020 p-valueAge (years) 71.2 ± 12.265.0 ± 12.1 p<0.01 NSTEMI patients 5659P=NSNSTEMI undergoing angiography 5053P=NS Median Time to angiography (hours) 68.614 p<0.01 Median length of stay (days)5 (IQR 2:8)2 (IQR 1:4) p<0.01 Referral to cardiac rehabilitation 77.4% 84.5% P=NS Prescription of secondary prevention medication 69.8% 72.4% P=NS. Conclusion Our results show that the mean age of the patients presenting with NSTEMI during the peak of the Covid-19 pandemic was younger suggesting that elderly patients failed to present. Compared to 2019, there was a significant improvement in patient treatment times with a significantly shorter stay in the hospital, probably as a result of the reduction in elective activity allowing un-restrained access to the catheter labs. We also saw improvement in prescription for secondary prevention and referral to cardiac rehabilitation services during this time suggesting that there may have been improved focus on these aspects of care again.

SELECTION OF CITATIONS
SEARCH DETAIL